Skip to main content

Table 2 Proportion of individuals reaching LDL-C target

From: Lifetime risk assessment in cholesterol management among hypertensive patients: observational cross-sectional study based on electronic health record data

 Age 30–49Age 50–59Age 60–69Age 70–79Age 80 -Total
LDL-C TARGET REACHED
Women without LLM
  Yes, n (%)119 (50.4)132 (37.5)250 (41.5)235 (47.2)192 (55.7)928 (45.6)
Women with LLM
   Yes, n (%)15 (55.6)75 (48.1)436 (62.1)595 (70.0)383 (66.6)1504 (65.1)
Men without LLM
   Yes, n (%)80 (41.2)100 (36.8)207 (46.1)175 (54.4)90 (66.2)652 (47.5)
Men with LLM
   Yes, n (%)27 (42.9)90 (54.9)362 (68.2)337 (71.6)121 (70.8)937 (66.9)
LIPID-LOWERING MEDICATION
Women
  Yes, n (%)27 (10.3)156 (30.7)702 (53.8)850 (63.0)575 (62.5)2310 (53.2)
 Men
  Yes, n (%)63 (24.5)164 (37.6)531 (54.2)471 (59.4)171 (55.7)1400 (50.5)
  1. Abbreviations. LDL-C low-density lipoprotein, LLM lipid-lowering medication